메뉴 건너뛰기




Volumn 986, Issue , 2013, Pages 171-187

TGF beta signaling and its role in glioma pathogenesis

Author keywords

Activin receptor like kinases; Gliomas; MAP kinases; Smad proteins; TGF receptors; TGF signaling

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; LERDELIMUMAB; LY 2109761; METELIMUMAB; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TEMOZOLOMIDE; TRABEDERSEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

EID: 84867530190     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4719-7_9     Document Type: Article
Times cited : (118)

References (117)
  • 1
    • 0028953810 scopus 로고
    • Transforming growth factor beta and cell cycle regulation
    • Alexandrow MG, Moses HL (1995) Transforming growth factor beta and cell cycle regulation. Cancer Res 55:1452-14577
    • (1995) Cancer Res , vol.55 , pp. 1452-14577
    • Alexandrow, M.G.1    Moses, H.L.2
  • 3
    • 2942653435 scopus 로고    scopus 로고
    • Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1
    • Annes JP, Chen Y, Munger JS, Rifkin DB (2004) Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 165:723-7344
    • (2004) J Cell Biol , vol.165 , pp. 723-7344
    • Annes, J.P.1    Chen, Y.2    Munger, J.S.3    Rifkin, D.B.4
  • 4
    • 34248599025 scopus 로고    scopus 로고
    • The role of versican isoforms V0/ V1 in glioma migration mediated by transforming growth factor-beta2
    • Arslan F, Bosserhoff AK, Nickl-Jockschat T, Doerfelt A, Bogdahn U, Hau P (2007) The role of versican isoforms V0/ V1 in glioma migration mediated by transforming growth factor-beta2. Br J Cancer 96:1560-15688
    • (2007) Br J Cancer , vol.96 , pp. 1560-15688
    • Arslan, F.1    Bosserhoff, A.K.2    Nickl-Jockschat, T.3    Doerfelt, A.4    Bogdahn, U.5    Hau, P.6
  • 5
    • 0037204990 scopus 로고    scopus 로고
    • Signal transduction by the TGF-beta superfamily
    • Attisano L, Wrana JL (2002) Signal transduction by the TGF-beta superfamily. Science 296:1646-16477
    • (2002) Science , vol.296 , pp. 1646-16477
    • Attisano, L.1    Wrana, J.L.2
  • 6
    • 0035865146 scopus 로고    scopus 로고
    • Role of TGF-beta in immune-evasion of cancer
    • Beck C, Schreiber H, Rowley D (2001) Role of TGF-beta in immune-evasion of cancer. Microsc Res Tech 52:387-3955
    • (2001) Microsc Res Tech , vol.52 , pp. 387-3955
    • Beck, C.1    Schreiber, H.2    Rowley, D.3
  • 8
    • 0035861541 scopus 로고    scopus 로고
    • Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity
    • Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL (2001) Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem 276:46707-467133
    • (2001) J Biol Chem , vol.276 , pp. 46707-467133
    • Bhowmick, N.A.1    Zent, R.2    Ghiassi, M.3    McDonnell, M.4    Moses, H.L.5
  • 11
    • 0033773180 scopus 로고    scopus 로고
    • The transforming growth factor-betas: Structure, signaling, and roles in nervous system development and functions
    • Bottner M, Krieglstein K, Unsicker K (2000) The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 75:2227-22400
    • (2000) J Neurochem , vol.75 , pp. 2227-22400
    • Bottner, M.1    Krieglstein, K.2    Unsicker, K.3
  • 12
    • 33846821916 scopus 로고    scopus 로고
    • High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
    • Bruna A, Darken RS, Rojo F, Ocana A, Penuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J, Seoane J (2007) High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11:147-1600
    • (2007) Cancer Cell , vol.11 , pp. 147-1600
    • Bruna, A.1    Darken, R.S.2    Rojo, F.3    Ocana, A.4    Penuelas, S.5    Arias, A.6    Paris, R.7    Tortosa, A.8    Mora, J.9    Baselga, J.10    Seoane, J.11
  • 13
    • 19544368642 scopus 로고    scopus 로고
    • Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: An angiogenic control switch
    • Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G, Einheber S, Boudreau N, Nishimura SL (2005) Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am J Pathol 166:1883-18944
    • (2005) Am J Pathol , vol.166 , pp. 1883-18944
    • Cambier, S.1    Gline, S.2    Mu, D.3    Collins, R.4    Araya, J.5    Dolganov, G.6    Einheber, S.7    Boudreau, N.8    Nishimura, S.L.9
  • 15
    • 0037067653 scopus 로고    scopus 로고
    • E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression
    • Chen CR, Kang Y, Siegel PM, Massague J (2002) E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110:19-322
    • (2002) Cell , vol.110 , pp. 19-322
    • Chen, C.R.1    Kang, Y.2    Siegel, P.M.3    Massague, J.4
  • 17
    • 75749136051 scopus 로고    scopus 로고
    • TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
    • Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier LL, Parsa AT (2010) TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol 12:7-133
    • (2010) Neuro Oncol , vol.12 , pp. 7-133
    • Crane, C.A.1    Han, S.J.2    Barry, J.J.3    Ahn, B.J.4    Lanier, L.L.5    Parsa, A.T.6
  • 18
    • 1342265719 scopus 로고    scopus 로고
    • SB-505124 is a selective inhibitor of transforming growth factor-beta type i receptors ALK4, ALK5, and ALK7
    • DaCosta Byfield S, Major C, Laping NJ, Roberts AB (2004) SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65:744-7522
    • (2004) Mol Pharmacol , vol.65 , pp. 744-7522
    • Dacosta Byfield, S.1    Major, C.2    Laping, N.J.3    Roberts, A.B.4
  • 19
    • 0142104985 scopus 로고    scopus 로고
    • Smad-dependent and Smad-independent pathways in TGF-beta family signalling
    • Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-5844
    • (2003) Nature , vol.425 , pp. 577-5844
    • Derynck, R.1    Zhang, Y.E.2
  • 20
    • 0028906190 scopus 로고
    • Processing of transforming growth factor beta 1 precursor by human furin convertase
    • Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R (1995) Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270:10618-106244
    • (1995) J Biol Chem , vol.270 , pp. 10618-106244
    • Dubois, C.M.1    Laprise, M.H.2    Blanchette, F.3    Gentry, L.E.4    Leduc, R.5
  • 21
    • 33846817212 scopus 로고    scopus 로고
    • Cross-talk between Smad and p38 MAPK signalling in transforming growth factor beta signal transduction in human glioblastoma cells
    • Dziembowska M, Danilkiewicz M, Wesolowska A, Zupanska A, Chouaib S, Kaminska B (2007) Cross-talk between Smad and p38 MAPK signalling in transforming growth factor beta signal transduction in human glioblastoma cells. Biochem Biophys Res Commun 354:1101-11066
    • (2007) Biochem Biophys Res Commun , vol.354 , pp. 1101-11066
    • Dziembowska, M.1    Danilkiewicz, M.2    Wesolowska, A.3    Zupanska, A.4    Chouaib, S.5    Kaminska, B.6
  • 22
    • 0036197606 scopus 로고    scopus 로고
    • Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA
    • Edlund S, Landstrom M, Heldin CH, Aspenstrom P (2002) Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 13:902-9144
    • (2002) Mol Biol Cell , vol.13 , pp. 902-9144
    • Edlund, S.1    Landstrom, M.2    Heldin, C.H.3    Aspenstrom, P.4
  • 24
    • 5644248080 scopus 로고    scopus 로고
    • RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
    • Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, Weller M (2004) RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res 64:7596-76033
    • (2004) Cancer Res , vol.64 , pp. 7596-76033
    • Friese, M.A.1    Wischhusen, J.2    Wick, W.3    Weiler, M.4    Eisele, G.5    Steinle, A.6    Weller, M.7
  • 25
    • 0034770605 scopus 로고    scopus 로고
    • Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells
    • Gorelik L, Flavell RA (2001) Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med 7:1118-11222
    • (2001) Nat Med , vol.7 , pp. 1118-11222
    • Gorelik, L.1    Flavell, R.A.2
  • 26
    • 0033625416 scopus 로고    scopus 로고
    • Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice
    • Goumans MJ, Mummery C (2000) Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44:253-2655
    • (2000) Int J Dev Biol , vol.44 , pp. 253-2655
    • Goumans, M.J.1    Mummery, C.2
  • 27
    • 0037007226 scopus 로고    scopus 로고
    • Balancing the activation state of the endothelium via two distinct TGF-beta type i receptors
    • Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21:1743-17533
    • (2002) EMBO J , vol.21 , pp. 1743-17533
    • Goumans, M.J.1    Valdimarsdottir, G.2    Itoh, S.3    Rosendahl, A.4    Sideras, P.5    Ten Dijke, P.6
  • 28
    • 0029029807 scopus 로고
    • Release and activation of platelet latent TGFbeta in blood clots during dissolution with plasmin
    • Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC (1995) Release and activation of platelet latent TGFbeta in blood clots during dissolution with plasmin. Nat Med 1:932-9377
    • (1995) Nat Med , vol.1 , pp. 932-9377
    • Grainger, D.J.1    Wakefield, L.2    Bethell, H.W.3    Farndale, R.W.4    Metcalfe, J.C.5
  • 34
    • 0038717313 scopus 로고    scopus 로고
    • Interaction of transforming growth factorbeta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells
    • Held-Feindt J, Lutjohann B, Ungefroren H, Mehdorn HM, Mentlein R (2003) Interaction of transforming growth factorbeta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells. J Neurooncol 63:117-1277
    • (2003) J Neurooncol , vol.63 , pp. 117-1277
    • Held-Feindt, J.1    Lutjohann, B.2    Ungefroren, H.3    Mehdorn, H.M.4    Mentlein, R.5
  • 36
    • 3042838388 scopus 로고    scopus 로고
    • Latent TGF-beta binding proteins: Extracellular matrix association and roles in TGF-beta activation
    • Hyytiainen M, Penttinen C, Keski-Oja J (2004) Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 41:233-2644
    • (2004) Crit Rev Clin Lab Sci , vol.41 , pp. 233-2644
    • Hyytiainen, M.1    Penttinen, C.2    Keski-Oja, J.3
  • 38
    • 70350497349 scopus 로고    scopus 로고
    • Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors
    • Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K (2009) Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5:504-5144
    • (2009) Cell Stem Cell , vol.5 , pp. 504-5144
    • Ikushima, H.1    Todo, T.2    Ino, Y.3    Takahashi, M.4    Miyazawa, K.5    Miyazono, K.6
  • 39
    • 33847716712 scopus 로고    scopus 로고
    • Negative regulation of TGF-beta receptor/Smad signal transduction
    • Itoh S, ten Dijke P (2007) Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol 19:176-1844
    • (2007) Curr Opin Cell Biol , vol.19 , pp. 176-1844
    • Itoh, S.1    Ten Dijke, P.2
  • 40
    • 0027223428 scopus 로고
    • The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma
    • Jachimczak P, Bogdahn U, Schneider J, Behl C, Meixensberger J, Apfel R, Dorries R, Schlingensiepen KH, Brysch W (1993) The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J Neurosurg 78:944-9511
    • (1993) J Neurosurg , vol.78 , pp. 944-9511
    • Jachimczak, P.1    Bogdahn, U.2    Schneider, J.3    Behl, C.4    Meixensberger, J.5    Apfel, R.6    Dorries, R.7    Schlingensiepen, K.H.8    Brysch, W.9
  • 42
    • 0031930657 scopus 로고    scopus 로고
    • The role of transforming growth factor beta in glioma progression
    • Jennings MT, Pietenpol JA (1998) The role of transforming growth factor beta in glioma progression. J Neurooncol 36:123-1400
    • (1998) J Neurooncol , vol.36 , pp. 123-1400
    • Jennings, M.T.1    Pietenpol, J.A.2
  • 43
    • 0025895774 scopus 로고
    • TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: Evidence in support of an autocrine hypothesis
    • Jennings MT, Maciunas RJ, Carver R, Bascom CC, Juneau P, Misulis K, Moses HL (1991) TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis. Int J Cancer 49:129-1399
    • (1991) Int J Cancer , vol.49 , pp. 129-1399
    • Jennings, M.T.1    MacIunas, R.J.2    Carver, R.3    Bascom, C.C.4    Juneau, P.5    Misulis, K.6    Moses, H.L.7
  • 44
    • 67650364197 scopus 로고    scopus 로고
    • Molecular characterization of in fl ammation-induced JNK/c-Jun signaling pathway in connection with tumorigenesis
    • Kaminska B (2009) Molecular characterization of in fl ammation-induced JNK/c-Jun signaling pathway in connection with tumorigenesis. Methods Mol Biol 512:249-2644
    • (2009) Methods Mol Biol , vol.512 , pp. 249-2644
    • Kaminska, B.1
  • 45
    • 0242581709 scopus 로고    scopus 로고
    • Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression
    • Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, Delaisse JM, Foged NT (2003) Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J Biol Chem 278:44975-449877
    • (2003) J Biol Chem , vol.278 , pp. 44975-449877
    • Karsdal, M.A.1    Hjorth, P.2    Henriksen, K.3    Kirkegaard, T.4    Nielsen, K.L.5    Lou, H.6    Delaisse, J.M.7    Foged, N.T.8
  • 46
    • 34748861947 scopus 로고    scopus 로고
    • A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy
    • Khaw P, Grehn F, Hollo G, Overton B, Wilson R, Vogel R, Smith Z (2007) A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 114:1822-18300
    • (2007) Ophthalmology , vol.114 , pp. 1822-18300
    • Khaw, P.1    Grehn, F.2    Hollo, G.3    Overton, B.4    Wilson, R.5    Vogel, R.6    Smith, Z.7
  • 49
    • 24344483878 scopus 로고    scopus 로고
    • Smad4 dependency defines two classes of transforming growth factor beta (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses
    • Levy L, Hill CS (2005) Smad4 dependency defines two classes of transforming growth factor beta (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol Cell Biol 25:8108-81255
    • (2005) Mol Cell Biol , vol.25 , pp. 8108-81255
    • Levy, L.1    Hill, C.S.2
  • 50
    • 0031698247 scopus 로고    scopus 로고
    • Prolonged survival of rats with intracranial C6 gliomas by treatment with TGFbeta antisense gene
    • Liau LM, Fakhrai H, Black KL (1998) Prolonged survival of rats with intracranial C6 gliomas by treatment with TGFbeta antisense gene. Neurol Res 20:742-7477
    • (1998) Neurol Res , vol.20 , pp. 742-7477
    • Liau, L.M.1    Fakhrai, H.2    Black, K.L.3
  • 51
    • 4544256756 scopus 로고    scopus 로고
    • Cytoplasmic PML function in TGF-beta signalling
    • Lin HK, Bergmann S, Pandol fi PP (2004) Cytoplasmic PML function in TGF-beta signalling. Nature 431:205-211
    • (2004) Nature , vol.431 , pp. 205-211
    • Lin, H.K.1    Bergmann, S.2    Pandolfi, P.P.3
  • 52
    • 0026510668 scopus 로고
    • Transforming growth factor-beta 1 in the rat brain: Increase after injury and inhibition of astrocyte proliferation
    • Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H (1992) Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 117:395-4000
    • (1992) J Cell Biol , vol.117 , pp. 395-4000
    • Lindholm, D.1    Castren, E.2    Kiefer, R.3    Zafra, F.4    Thoenen, H.5
  • 53
    • 33845684545 scopus 로고    scopus 로고
    • TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors
    • Liu Y, Wang Q, Kleinschmidt-DeMasters BK, Franzusoff A, Ng KY, Lillehei KO (2007) TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors. J Neurooncol 81:149-1622
    • (2007) J Neurooncol , vol.81 , pp. 149-1622
    • Liu, Y.1    Wang, Q.2    Kleinschmidt-Demasters, B.K.3    Franzusoff, A.4    Ng, K.Y.5    Lillehei, K.O.6
  • 54
    • 79953045754 scopus 로고    scopus 로고
    • TGF-beta1 promotes motility and invasiveness of glioma cells through activation of ADAM17
    • Lu Y, Jiang F, Zheng X, Katakowski M, Buller B, To SS, Chopp M (2011) TGF-beta1 promotes motility and invasiveness of glioma cells through activation of ADAM17. Oncol Rep 25:1329-13355
    • (2011) Oncol Rep , vol.25 , pp. 1329-13355
    • Lu, Y.1    Jiang, F.2    Zheng, X.3    Katakowski, M.4    Buller, B.5    To, S.S.6    Chopp, M.7
  • 55
    • 0028972556 scopus 로고
    • TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice
    • Maeda H, Kuwahara H, Ichimura Y, Ohtsuki M, Kurakata S, Shiraishi A (1995) TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol 155:4926-49322
    • (1995) J Immunol , vol.155 , pp. 4926-49322
    • Maeda, H.1    Kuwahara, H.2    Ichimura, Y.3    Ohtsuki, M.4    Kurakata, S.5    Shiraishi, A.6
  • 56
    • 47549090432 scopus 로고    scopus 로고
    • TGFbeta in cancer
    • Massague J (2008) TGFbeta in cancer. Cell 134:215-2300
    • (2008) Cell , vol.134 , pp. 215-2300
    • Massague, J.1
  • 57
    • 0034678908 scopus 로고    scopus 로고
    • Transcriptional control by the TGF-beta/Smad signaling system
    • Massague J, Wotton D (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19:1745-17544
    • (2000) EMBO J , vol.19 , pp. 1745-17544
    • Massague, J.1    Wotton, D.2
  • 58
  • 59
    • 0041342109 scopus 로고    scopus 로고
    • Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery
    • Mead AL, Wong TT, Cordeiro MF, Anderson IK, Khaw PT (2003) Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci 44:3394-34011
    • (2003) Invest Ophthalmol Vis Sci , vol.44 , pp. 3394-34011
    • Mead, A.L.1    Wong, T.T.2    Cordeiro, M.F.3    Anderson, I.K.4    Khaw, P.T.5
  • 60
    • 42249099019 scopus 로고    scopus 로고
    • LY2109761, a novel transforming growth factor beta receptor type i and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
    • Melisi D, Ishiyama S, Sclabas GM, Fleming JB, Xia Q, Tortora G, Abbruzzese JL, Chiao PJ (2008) LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther 7:829-8400
    • (2008) Mol Cancer Ther , vol.7 , pp. 829-8400
    • Melisi, D.1    Ishiyama, S.2    Sclabas, G.M.3    Fleming, J.B.4    Xia, Q.5    Tortora, G.6    Abbruzzese, J.L.7    Chiao, P.J.8
  • 62
    • 24944497786 scopus 로고    scopus 로고
    • Non-Smad TGF-beta signals
    • Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. J Cell Sci 118:3573-35844
    • (2005) J Cell Sci , vol.118 , pp. 3573-35844
    • Moustakas, A.1    Heldin, C.H.2
  • 63
    • 0035694910 scopus 로고    scopus 로고
    • Smad regulation in TGF-beta signal transduction
    • Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114:4359-43699
    • (2001) J Cell Sci , vol.114 , pp. 4359-43699
    • Moustakas, A.1    Souchelnytskyi, S.2    Heldin, C.H.3
  • 65
    • 0034023127 scopus 로고    scopus 로고
    • Role of Ras and Mapks in TGFbeta signaling
    • Mulder KM (2000) Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11:23-355
    • (2000) Cytokine Growth Factor Rev , vol.11 , pp. 23-355
    • Mulder, K.M.1
  • 68
    • 56649117546 scopus 로고    scopus 로고
    • Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling
    • Pen A, Moreno MJ, Durocher Y, Deb-Rinker P, Stanimirovic DB (2008) Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling. Oncogene 27:6834-68444
    • (2008) Oncogene , vol.27 , pp. 6834-68444
    • Pen, A.1    Moreno, M.J.2    Durocher, Y.3    Deb-Rinker, P.4    Stanimirovic, D.B.5
  • 69
    • 0036272313 scopus 로고    scopus 로고
    • Internalization-dependent and-independent requirements for transforming growth factor beta receptor signaling via the Smad pathway
    • Penheiter SG, Mitchell H, Garamszegi N, Edens M, Dore JJ Jr, Leof EB (2002) Internalization-dependent and-independent requirements for transforming growth factor beta receptor signaling via the Smad pathway. Mol Cell Biol 22:4750-47599
    • (2002) Mol Cell Biol , vol.22 , pp. 4750-47599
    • Penheiter, S.G.1    Mitchell, H.2    Garamszegi, N.3    Edens, M.4    Dore Jr., J.J.5    Leof, E.B.6
  • 71
    • 0031106404 scopus 로고    scopus 로고
    • Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
    • Pepper MS (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21-433
    • (1997) Cytokine Growth Factor Rev , vol.8 , pp. 21-433
    • Pepper, M.S.1
  • 72
    • 0032943080 scopus 로고    scopus 로고
    • Expression of transforminggrowth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1
    • Piek E, Westermark U, Kastemar M, Heldin CH, van Zoelen EJ, Nister M, Ten Dijke P (1999) Expression of transforminggrowth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1. Int J Cancer 80:756-7633
    • (1999) Int J Cancer , vol.80 , pp. 756-7633
    • Piek, E.1    Westermark, U.2    Kastemar, M.3    Heldin, C.H.4    Van Zoelen, E.J.5    Nister, M.6    Ten Dijke, P.7
  • 73
    • 0034673243 scopus 로고    scopus 로고
    • Transforming growth factors beta (1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression
    • Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J, Weller M (2000) Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression. Biochem Biophys Res Commun 268:607-6111
    • (2000) Biochem Biophys Res Commun , vol.268 , pp. 607-6111
    • Platten, M.1    Wick, W.2    Wild-Bode, C.3    Aulwurm, S.4    Dichgans, J.5    Weller, M.6
  • 74
    • 0035865158 scopus 로고    scopus 로고
    • Malignant glioma biology: Role for TGF-beta in growth, motility, angiogenesis, and immune escape
    • Platten M, Wick W, Weller M (2001) Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52:401-4100
    • (2001) Microsc Res Tech , vol.52 , pp. 401-4100
    • Platten, M.1    Wick, W.2    Weller, M.3
  • 75
    • 0041737535 scopus 로고    scopus 로고
    • Molecular mechanisms of glioma invasiveness: The role of proteases
    • Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489-5011
    • (2003) Nat Rev Cancer , vol.3 , pp. 489-5011
    • Rao, J.S.1
  • 76
    • 0033532054 scopus 로고    scopus 로고
    • The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factorbeta
    • Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factorbeta. J Biol Chem 274:13586-135933
    • (1999) J Biol Chem , vol.274 , pp. 13586-135933
    • Ribeiro, S.M.1    Poczatek, M.2    Schultz-Cherry, S.3    Villain, M.4    Murphy-Ullrich, J.E.5
  • 77
    • 3142730646 scopus 로고    scopus 로고
    • The role of transforming growth factor-beta in primary brain tumors
    • Rich JN (2003) The role of transforming growth factor-beta in primary brain tumors. Front Biosci 8:e245-e2600
    • (2003) Front Biosci , vol.8
    • Rich, J.N.1
  • 78
    • 0033521118 scopus 로고    scopus 로고
    • Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines
    • Rich JN, Zhang M, Datto MB, Bigner DD, Wang XF (1999) Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J Biol Chem 274:35053-350588
    • (1999) J Biol Chem , vol.274 , pp. 35053-350588
    • Rich, J.N.1    Zhang, M.2    Datto, M.B.3    Bigner, D.D.4    Wang, X.F.5
  • 79
    • 77954527232 scopus 로고    scopus 로고
    • Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists
    • Rider CC, Mulloy B (2010) Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochem J 429:1-122
    • (2010) Biochem J , vol.429 , pp. 1-122
    • Rider, C.C.1    Mulloy, B.2
  • 80
    • 0035914297 scopus 로고    scopus 로고
    • Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression
    • Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L, Bernabeu C (2001) Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276:38527-385355
    • (2001) J Biol Chem , vol.276 , pp. 38527-385355
    • Sanchez-Elsner, T.1    Botella, L.M.2    Velasco, B.3    Corbi, A.4    Attisano, L.5    Bernabeu, C.6
  • 84
    • 38449103630 scopus 로고    scopus 로고
    • Antisense therapeutics for tumor treatment: The TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors
    • Schlingensiepen KH, Fischer-Blass B, Schmaus S, Ludwig S (2008) Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors. Cancer Res 177:137-1500
    • (2008) Cancer Res , vol.177 , pp. 137-1500
    • Schlingensiepen, K.H.1    Fischer-Blass, B.2    Schmaus, S.3    Ludwig, S.4
  • 85
    • 36448936383 scopus 로고    scopus 로고
    • TGFbeta-SMAD signal transduction: Molecular specificity and functional flexibility
    • Schmierer B, Hill CS (2007) TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8:970-9822
    • (2007) Nat Rev Mol Cell Biol , vol.8 , pp. 970-9822
    • Schmierer, B.1    Hill, C.S.2
  • 86
    • 43249108418 scopus 로고    scopus 로고
    • The TGFBeta pathway as a therapeutic target in cancer
    • Seoane J (2008) The TGFBeta pathway as a therapeutic target in cancer. Clin Transl Oncol 10:14-199
    • (2008) Clin Transl Oncol , vol.10 , pp. 14-199
    • Seoane, J.1
  • 88
    • 1642332084 scopus 로고    scopus 로고
    • Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation
    • Seoane J, Le HV, Shen L, Anderson SA, Massague J (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117:211-2233
    • (2004) Cell , vol.117 , pp. 211-2233
    • Seoane, J.1    Le Shen, H.V.L.2    Anderson, S.A.3    Massague, J.4
  • 89
    • 0038682002 scopus 로고    scopus 로고
    • Mechanisms of TGF-beta signaling from cell membrane to the nucleus
    • Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-7000
    • (2003) Cell , vol.113 , pp. 685-7000
    • Shi, Y.1    Massague, J.2
  • 90
    • 0037816160 scopus 로고    scopus 로고
    • Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis
    • Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J (2003a) Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A 100:8430-84355
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 8430-84355
    • Siegel, P.M.1    Shu, W.2    Cardiff, R.D.3    Muller, W.J.4    Massague, J.5
  • 91
    • 0042316912 scopus 로고    scopus 로고
    • Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-beta-mediated epithelial cell growth suppression
    • Siegel PM, Shu W, Massague J (2003b) Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-beta-mediated epithelial cell growth suppression. J Biol Chem 278:35444-354500
    • (2003) J Biol Chem , vol.278 , pp. 35444-354500
    • Siegel, P.M.1    Shu, W.2    Massague, J.3
  • 92
    • 0025858872 scopus 로고
    • Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta
    • Smyth MJ, Strobl SL, Young HA, Ortaldo JR, Ochoa AC (1991) Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol 146:3289-32977
    • (1991) J Immunol , vol.146 , pp. 3289-32977
    • Smyth, M.J.1    Strobl, S.L.2    Young, H.A.3    Ortaldo, J.R.4    Ochoa, A.C.5
  • 94
    • 47349086991 scopus 로고    scopus 로고
    • MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1
    • Tatti O, Vehvilainen P, Lehti K, Keski-Oja J (2008) MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. Exp Cell Res 314:2501-25144
    • (2008) Exp Cell Res , vol.314 , pp. 2501-25144
    • Tatti, O.1    Vehvilainen, P.2    Lehti, K.3    Keski-Oja, J.4
  • 95
    • 80054044019 scopus 로고    scopus 로고
    • Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by {beta}8 integrin
    • Tchaicha JH, Reyes SB, Shin J, Hossain MG, Lang FF, McCarty JH (2011) Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by {beta}8 integrin. Cancer Res 71:6371-63811
    • (2011) Cancer Res , vol.71 , pp. 6371-63811
    • Tchaicha, J.H.1    Reyes, S.B.2    Shin, J.3    Hossain, M.G.4    Lang, F.F.5    McCarty, J.H.6
  • 96
    • 2342488852 scopus 로고    scopus 로고
    • New insights into TGF-beta-Smad signalling
    • ten Dijke P, Hill CS (2004) New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29:265-2733
    • (2004) Trends Biochem Sci , vol.29 , pp. 265-2733
    • Ten Dijke, P.1    Hill, C.S.2
  • 97
    • 77952043572 scopus 로고    scopus 로고
    • RNAi-based therapeutics-current status, challenges and prospects
    • Tiemann K, Rossi JJ (2009) RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol Med 1:142-1511
    • (2009) EMBO Mol Med , vol.1 , pp. 142-1511
    • Tiemann, K.1    Rossi, J.J.2
  • 99
    • 0032428684 scopus 로고    scopus 로고
    • SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor
    • Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95:779-7911
    • (1998) Cell , vol.95 , pp. 779-7911
    • Tsukazaki, T.1    Chiang, T.A.2    Davison, A.F.3    Attisano, L.4    Wrana, J.L.5
  • 100
    • 70350708139 scopus 로고    scopus 로고
    • Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines
    • Ueda R, Fujita M, Zhu X, Sasaki K, Kastenhuber ER, Kohanbash G, McDonald HA, Harper J, Lonning S, Okada H (2009) Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines. Clin Cancer Res 15:6551-65599
    • (2009) Clin Cancer Res , vol.15 , pp. 6551-65599
    • Ueda, R.1    Fujita, M.2    Zhu, X.3    Sasaki, K.4    Kastenhuber, E.R.5    Kohanbash, G.6    McDonald, H.A.7    Harper, J.8    Lonning, S.9    Okada, H.10
  • 102
    • 0024278715 scopus 로고
    • Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells
    • Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB (1988) Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 263:7741-77466
    • (1988) J Biol Chem , vol.263 , pp. 7741-77466
    • Van Obberghen-Schilling, E.1    Roche, N.S.2    Flanders, K.C.3    Sporn, M.B.4    Roberts, A.B.5
  • 103
    • 0036177427 scopus 로고    scopus 로고
    • Transforming growth factor-beta signaling through the Smad pathway: Role in extracellular matrix gene expression and regulation
    • Verrecchia F, Mauviel A (2002) Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118:211-2155
    • (2002) J Invest Dermatol , vol.118 , pp. 211-2155
    • Verrecchia, F.1    Mauviel, A.2
  • 104
    • 80051471864 scopus 로고    scopus 로고
    • The specificities of small molecule inhibitors of the TGFss and BMP pathways
    • 1831-18422
    • Vogt J, Traynor R, Sapkota GP (2011) The specificities of small molecule inhibitors of the TGFss and BMP pathways. Cell Signal 23:1831-18422
    • (2011) Cell Signal , vol.23
    • Vogt, J.1    Traynor, R.2    Sapkota, G.P.3
  • 105
    • 0032478791 scopus 로고    scopus 로고
    • Transforming growth factor-beta1 stimulates protein kinase A in mesangial cells
    • Wang L, Zhu Y, Sharma K (1998) Transforming growth factor-beta1 stimulates protein kinase A in mesangial cells. J Biol Chem 273:8522-85277
    • (1998) J Biol Chem , vol.273 , pp. 8522-85277
    • Wang, L.1    Zhu, Y.2    Sharma, K.3
  • 106
    • 38949165993 scopus 로고    scopus 로고
    • Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor
    • Wesolowska A, Kwiatkowska A, Slomnicki L, Dembinski M, Master A, Sliwa M, Franciszkiewicz K, Chouaib S, Kaminska B (2008) Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Oncogene 27:918-9300
    • (2008) Oncogene , vol.27 , pp. 918-9300
    • Wesolowska, A.1    Kwiatkowska, A.2    Slomnicki, L.3    Dembinski, M.4    Master, A.5    Sliwa, M.6    Franciszkiewicz, K.7    Chouaib, S.8    Kaminska, B.9
  • 107
    • 0034765067 scopus 로고    scopus 로고
    • Glioma cell invasion: Regulation of metalloproteinase activity by TGF-beta
    • Wick W, Platten M, Weller M (2001) Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol 53:177-1855
    • (2001) J Neurooncol , vol.53 , pp. 177-1855
    • Wick, W.1    Platten, M.2    Weller, M.3
  • 108
    • 0242721599 scopus 로고    scopus 로고
    • Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3
    • Wilkes MC, Murphy SJ, Garamszegi N, Leof EB (2003) Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3. Mol Cell Biol 23:8878-88899
    • (2003) Mol Cell Biol , vol.23 , pp. 8878-88899
    • Wilkes, M.C.1    Murphy, S.J.2    Garamszegi, N.3    Leof, E.B.4
  • 109
    • 0033559577 scopus 로고    scopus 로고
    • Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy
    • Won J, Kim H, Park EJ, Hong Y, Kim SJ, Yun Y (1999) Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy. Cancer Res 59:1273-12777
    • (1999) Cancer Res , vol.59 , pp. 1273-12777
    • Won, J.1    Kim, H.2    Park, E.J.3    Hong, Y.4    Kim, S.J.5    Yun, Y.6
  • 110
    • 0032979988 scopus 로고    scopus 로고
    • Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta
    • Wong C, Rougier-Chapman EM, Frederick JP, Datto MB, Liberati NT, Li JM, Wang XF (1999) Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol 19:1821-18300
    • (1999) Mol Cell Biol , vol.19 , pp. 1821-18300
    • Wong, C.1    Rougier-Chapman, E.M.2    Frederick, J.P.3    Datto, M.B.4    Liberati, N.T.5    Li, J.M.6    Wang, X.F.7
  • 112
  • 113
    • 58149213801 scopus 로고    scopus 로고
    • Non-Smad pathways in TGF-beta signaling
    • Zhang YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19:128-1399
    • (2009) Cell Res , vol.19 , pp. 128-1399
    • Zhang, Y.E.1
  • 114
    • 33745532884 scopus 로고    scopus 로고
    • Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor
    • Zhang L, Sato E, Amagasaki K, Nakao A, Naganuma H (2006) Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor. J Neurosurg 105:119-1288
    • (2006) J Neurosurg , vol.105 , pp. 119-1288
    • Zhang, L.1    Sato, E.2    Amagasaki, K.3    Nakao, A.4    Naganuma, H.5
  • 115
    • 79960801821 scopus 로고    scopus 로고
    • Temozolomide decreases invasion of glioma stem cells by downregulating TGF-beta2
    • Zhang D, Jing Z, Qiu B, Wu A, Wang Y (2011a) Temozolomide decreases invasion of glioma stem cells by downregulating TGF-beta2. Oncol Rep 26:901-9088
    • (2011) Oncol Rep , vol.26 , pp. 901-9088
    • Zhang, D.1    Jing, Z.2    Qiu, B.3    Wu, A.4    Wang, Y.5
  • 116
    • 79958082880 scopus 로고    scopus 로고
    • Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-beta receptor i kinase inhibitor LY2109761
    • Zhang M, Herion TW, Timke C, Han N, Hauser K, Weber KJ, Peschke P, Wirkner U, Lahn M, Huber PE (2011b) Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-beta receptor I kinase inhibitor LY2109761. Neoplasia 13:537-5499
    • (2011) Neoplasia , vol.13 , pp. 537-5499
    • Zhang, M.1    Herion, T.W.2    Timke, C.3    Han, N.4    Hauser, K.5    Weber, K.J.6    Peschke, P.7    Wirkner, U.8    Lahn, M.9    Huber, P.E.10
  • 117
    • 79955924632 scopus 로고    scopus 로고
    • Increased transforming growth factor-beta2 in epidermal growth factor receptor variant III-positive glioblastoma
    • Zhang X, Wu A, Fan Y, Wang Y (2011c) Increased transforming growth factor-beta2 in epidermal growth factor receptor variant III-positive glioblastoma. J Clin Neurosci 18:821-8266
    • (2011) J Clin Neurosci , vol.18 , pp. 821-8266
    • Zhang, X.1    Wu, A.2    Fan, Y.3    Wang, Y.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.